Four experts report on the various experiences of cultivating cannabis for medicinal and industrial purposes in Brazil and abroad, mapping best practices and the main difficulties for the development of the activity

The study tested the anticonvulsant effects of CBGA in different preclinical seizure models. Among several patterns the cannabinoid was considered more effective than CBD in reducing seizures

In 2020, Epidiolex - which represents Jazz's third high-growth commercial franchise - surpassed 500 million dollars in annual net sales

Animal studies show that stimulating endocannabinoid receptors through cannabis can reduce inflammation related to infection and even decrease the overall mortality rate caused by the issue.

Khiron, Canopy Growth, and Ramm Pharma announced the registration of new products in July

George Wachsmann, head of management at Vitreo, the fintech managing the fund, spoke with the Sechat portal

Studies compiled in the Sechat Cannabis Guide show therapeutic benefits of CBD and acidic cannabinoids in horses, wildlife, and unconventional pets

Resolution No. 1,015/2026 tightens technical requirements, expands sanitary controls, and consolidates authorization as a transitional step before the registration of medicines

New RDC No. 1,011 expands regulatory details on Cannabis derivatives, medicinal products, and pharmaceutical inputs

Revision of RDC 327 allows the compounding sector to produce derivatives, while individual importation by individuals remains under old rules and will be analyzed separately

Lecture led by specialist will address scientific updates, clinical use, and regulation of cannabinoid therapies in Dentistry during the event in São Paulo

Process could determine whether the genetics will be classified as a genetically modified organism or treated as a conventional plant in Brazil

CTNBio's analysis focuses on the "Badger G" variety, which prioritizes industrial use and high levels of cannabigerol (CBG)

Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

Sector already generates €136 million, has over 500 stores, and operates below its potential due to outdated laws

Sector already generates €136 million, with over 500 stores and operating below potential due to outdated laws

Unanimous decision by the Fifth Panel reinforces patients' right to therapeutic planting upon medical proof and highlights the topic in an official report

Discover what medical cannabis is, what it is used for, and how this treatment has advanced in Brazil, with proven benefits and safe medical guidance.

Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.